{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:32:13Z","timestamp":1790465533465,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ijid.2021.01.025","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T14:33:18Z","timestamp":1610634798000},"page":"617-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study"],"prefix":"10.1016","volume":"104","author":[{"given":"Beno\u00eet","family":"Pilmis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Nguyen Van","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lourtet-Hasco\u00ebt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Voisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Le Lorc\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidonie","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"M\u00e9nage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Fran\u00e7oise","family":"Borie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo\u00efse","family":"Trabattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Ganansia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Ralph","family":"Zahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Le Monnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2021.01.025_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0732-8893(89)90045-X","article-title":"Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp","volume":"12","author":"Aldridge","year":"1989","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2021.01.025_bib0010","unstructured":"EUCAST: Clinical breakpoints. Available at http:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed August 5, 2016, n.d."},{"issue":"4","key":"10.1016\/j.ijid.2021.01.025_bib0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000238342","article-title":"Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration","volume":"31","author":"Borner","year":"1985","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2021.01.025_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2165\/00003495-198800352-00035","article-title":"Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy","volume":"35","author":"Br\u00e4utigam","year":"1988","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.ijid.2021.01.025_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02244-18","article-title":"Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens","volume":"63","author":"Burdet","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4A Suppl","key":"10.1016\/j.ijid.2021.01.025_bib0030","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.1016\/S0002-9610(06)80054-1","article-title":"reassessment of the activity of the third-generation cephalosporins against anaerobes and Staphylococcus aureus","volume":"164","author":"Canawati","year":"1992","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.ijid.2021.01.025_bib0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10096-018-3186-x","article-title":"Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients","volume":"37","author":"de Lastours","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ijid.2021.01.025_bib0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1017\/ice.2019.5","article-title":"ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome","volume":"40","author":"Emmanuel Martinez","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.ijid.2021.01.025_bib0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jinf.2016.07.014","article-title":"Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: a systematic review and meta-analysis","volume":"73","author":"Flokas Myrto","year":"2016","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.ijid.2021.01.025_bib0050","first-page":"370","article-title":"Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks","volume":"21","author":"Forestier","year":"2015","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2021.01.025_bib0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.medmal.2014.03.007","article-title":"Subcutaneous and intravenous ceftriaxone administration in patients more than 75 years of age","volume":"44","author":"Gauthier","year":"2014","journal-title":"Med Mal Infect"},{"issue":"2","key":"10.1016\/j.ijid.2021.01.025_bib0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/dks406","article-title":"Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes","volume":"68","author":"Gbaguidi-Haore","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2021.01.025_bib0065","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/jac\/dkt403","article-title":"Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime","volume":"69","author":"Grohs","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2021.01.025_bib0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00614206","article-title":"Ceftriaxone pharmacokinetics following multiple intramuscular dosing","volume":"30","author":"Holazo","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ijid.2021.01.025_bib0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new beta-lactamases","volume":"352","author":"Jacoby George","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ijid.2021.01.025_bib0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0248-8663(87)80198-4","article-title":"[Biliary excretion of cefotaxime and desacetylcefotaxime]","volume":"8","author":"Jehl","year":"1987","journal-title":"Rev Med Interne"},{"issue":"1\u20132","key":"10.1016\/j.ijid.2021.01.025_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0732-8893(95)00043-A","article-title":"Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review","volume":"22","author":"Jones","year":"1995","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2021.01.025_bib0090","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/infdis\/160.2.274","article-title":"Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization","volume":"160","author":"L\u00e9onard","year":"1989","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2021.01.025_bib0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00003495-198800352-00004","article-title":"Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study","volume":"35","author":"Mich\u00e9a-Hamzehpour","year":"1988","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ijid.2021.01.025_bib0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3855\/jidc.493","article-title":"Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria","volume":"4","author":"Mohanty","year":"2009","journal-title":"J Infect Dev Ctries"},{"issue":"4 Suppl","key":"10.1016\/j.ijid.2021.01.025_bib0105","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1093\/clinids\/4.Supplement_2.S346","article-title":"Levels of cefotaxime in body fluids and tissues: a review","author":"Novick","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2021.01.025_bib0110","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/AAC.05650-11","article-title":"Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States","volume":"56","author":"Park Yoon","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"4C","key":"10.1016\/j.ijid.2021.01.025_bib0115","first-page":"17","article-title":"Pharmacokinetic profile of ceftriaxone in man","volume":"77","author":"Patel","year":"1984","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ijid.2021.01.025_bib0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-140-1-200401060-00008","article-title":"International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections","volume":"140","author":"Paterson David","year":"2004","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ijid.2021.01.025_bib0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhin.2017.11.022","article-title":"Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study","volume":"98","author":"Pilmis","year":"2018","journal-title":"J Hosp Infect"},{"issue":"8","key":"10.1016\/j.ijid.2021.01.025_bib0130","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.00404-11","article-title":"Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae","volume":"49","author":"Polsfuss","year":"2011","journal-title":"J Clin Microbiol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:00:54Z","timestamp":1761120054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":26,"alternative-id":["S1201971221000357"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.01.025","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}